Company / PP&E per Share
Amylyx Pharmaceuticals, Inc. PP&E per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2025
5-year range
$0.00 / $0.37
FY2021-FY2025
Trend
-79.9%
vs FY2024
Sector context
#173 of 191
Health Care
What the data says
Among 191 Health Care companies, Amylyx Pharmaceuticals, Inc. is in the bottom 9% for pp&e per share. PP&E per Share has declined for 3 consecutive years, from $0.37 in FY2022 to $0.00 in FY2025.
Based on SEC 10-K filings.
0.00 in FY2025 with a 3-year CAGR of -80.4%.
Declined from $0.04 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -80.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 191This company $0.00 Sector average $22.34
▼
-100.0% below sector average
Key checks
Key Insights
- Amylyx Pharmaceuticals, Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 79.9% year-over-year.
- Ranks #173 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -79.9% |
| FY2024 | $0.01 | -64.7% |
| FY2023 | $0.04 | -89.3% |
| FY2022 | $0.37 | +416.8% |
| FY2021 | $0.07 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026